Author:
Krebs Teri S,Johansen Pål-Ørjan
Abstract
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference5 articles.
1. Hallucinogens.;D Nichols;Pharmacol Ther.,2004
2. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.;J González-Maeso;Neuron.,2007
3. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.;R Hallock;Drug Alcohol Depend.,2012
4. Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids.;C Andersson;Nordic Council of Ministers.,2009
5. The recanting of earlier reported drug use by young adults.;L Johnston;NIDA Res Monogr.,1997
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献